Anterior Segment Changes After Pars Plana Vitrectomy With SO Using AS-OCT (NCT06524661) | Clinical Trial Compass
CompletedNot Applicable
Anterior Segment Changes After Pars Plana Vitrectomy With SO Using AS-OCT
Egypt30 participantsStarted 2023-04-15
Plain-language summary
To evaluate changes in ACA induced by pars plana vitrectomy with SO 1000cs injection in vitreo-retinal surgery in phakic eyes using AS-OCT and changes in the IOP preoperatively, post-operatively and post-silicone oil evacuation.
Who can participate
Age range
16 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Patients with rhegmatogenous retinal detachment who are going to undergo vitreoretinal surgery with silicone oil 1000cs injection as tamponade
Exclusion Criteria:
* Patients with history of intraocular surgery, laser therapy or intravitreal injection.
* Patients with significant corneal opacity.
* Patients with ocular diseases as retinal vein occlusion, uveitis and proliferative diabetic retinopathy.
* Patients with preexisting glaucoma or family history of glaucoma.
* Patients with nystagmus.
* Patient with tractional retinal detachment, exudative retinal detachment or intraocular foreign body.
* Patients with anterior chamber abnormalities including posterior synechia, peripheral anterior synechia, hyphaema and iris abnormalities.
* Patients with severe proliferative vitreoretinopathy grade C or more.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Assessement of the changes in anterior chamber angle after vitrectomy with silicone oil injection
Timeframe: postoperative evaluation for 3 months duration (5 visits pre-ppv then one week, one month, three months )